Origin Therapeutics Announces New Director
Vancouver, B.C., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE: ORIG) (the “Company” or “Origin Therapeutics”), an...
News
Compass Therapeutics to Present at the 24th Annual H.C. Wainwright Global Investment Conference
BOSTON, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics...
TG Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Fireside chat available for on demand download beginning Monday, September 12 2022 at 7:00 AM ETNEW YORK, Sept. 09, 2022...
Excision BioTherapeutics to Present at Upcoming Conferences
SAN FRANCISCO, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Excision BioTherapeutics Inc., a clinical-stage biotechnology company developing CRISPR-based therapies intended to...
InflaRx to Present at Upcoming Scientific and Investor Conferences
JENA, Germany, Sept. 09, 2022 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by...
BioCardia Announces Participation at H.C. Wainwright Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE)
SUNNYVALE, Calif., Sept. 09, 2022 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ, BCDA), today announced it will be featured as a...
Instil Bio to Present at Morgan Stanley Global Healthcare Conference
DALLAS, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing...
Allakos Announces Topline Phase 3 Data from the EoDyssey Study in Patients with Eosinophilic Duodenitis
– Lirentelimab met histologic co-primary endpoint but missed symptomatic co-primary endpoint – SAN CARLOS, Calif., Sept. 09, 2022 (GLOBE NEWSWIRE)...
Tiziana Life Sciences Announces Purchase of Common Shares by Chief Medical Officer
NEW YORK, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company...
Asensus Surgical Announces Saiseikai Shiga Hospital in Japan to Initiate Senhance Surgery Program
Senhance Surgical System Senhance Surgical System is the first of its kind digital laparoscopic platform providing surgical assurance through haptic...
Nanox to Present at Two Upcoming Investor Conferences in September 2022
NEVE ILAN, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging...
Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History
Magic mushrooms are set to be analyzed, tested and ready for global distribution this fallVANCOUVER, British Columbia, Sept. 08, 2022...
Parexel Expands Network of Global Regulatory Experts
Five former regulators join Parexel’s Regulatory & Access Consulting team to help customers navigate the complex and evolving global regulatory...
THE OVARIAN CANCER COMMUNITY DEMANDS BETTER OUTCOMES
Support, Research, and Saving Lives Remains Focus of First in Person Ovarian Cancer Canada Walk of Hope since 2019 File...
Sorrento Therapeutics to Participate in Morgan Stanley 20th Annual Global Healthcare Conference September 12-14
SAN DIEGO, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced that Henry Ji, Ph.D.,...
Inovalon Achieves NCQA HEDIS® Measure Certification for Its 22nd Consecutive Year
Inovalon’s QSI-XL® Cloud Software Solution Empowers More Than 80% of the Nation’s Clinical Outcomes Measurement AnalyticsBOWIE, Md., Sept. 08, 2022...
Altamira Therapeutics to Host Investor Call on September 14th
HAMILTON, Bermuda, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that address...
ReWalk Robotics Appoints Michael Lawless as Chief Financial Officer
Brings Significant Experience in M&A, Investor Relations, and Financial StrategyMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- ReWalk...
Yield10 Bioscience to Present at the 24th Annual H.C. Wainwright Global Investment Conference
WOBURN, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience...
ICU Medical to Participate at the Morgan Stanley 20th Annual Global Healthcare Conference
SAN CLEMENTE, Calif., Sept. 08, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and...